Syncom Formulations India Q2 Results

  • BSE: 524470
  • NSE: SYNCOMF
  • ISIN: INE312C01025
  • Sector: Biotechnology & Drugs
BSE
19.580.07 (0.36%)
Volume4.85 L
Updated: Mon 25 Nov, 2024 | 15:55:07
NSE
19.580.08 (0.41%)
Volume1.97 M
Updated: Mon 25 Nov, 2024 | 15:40:23
Today: 19.51
20.31
52-Wk: 9.80
27.94

Q2 Results Highlights

  • Total Income
    ₹102.31 Cr.
    (17.26%)
  • Operating Profit
    ₹10.86 Cr.
    (18.65%)
  • Profit After Tax
    ₹11.11 Cr.
    (45.54%)
  • Operating Margin
    10.62%
    (22.60%)
Note: Comparison is on YoY basis

Quarterly - Syncom Formulations India Q2 Results

*All figures in crores except per share values
Fiscal PeriodSep 24Jun 23QoQ CompSep 23YoY Comp
Total Revenue 102.3159.84-%63.84-%
Selling/ General/ Admin Expenses Total 12.407.63-%9.00-%
Depreciation/ Amortization 1.301.10-%0.88-%
Other Operating Expenses Total 11.9510.20-%9.33-%
Total Operating Expense 91.4554.48-%58.31-%
Operating Income 10.865.36-%5.53-%
Net Income Before Taxes 14.856.11-%8.45-%
Net Income 11.114.40-%6.51-%
Diluted Normalized EPS 0.160.07-%0.08-%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumInstant LoanMint Shorts